CHP Merger Corp.
CHPMW
NASDAQ Capital Market0.00
USD
+0.00
- -
CIK
0001785041
Return %
Stock
S&P500
1Y
- -
18.21
3Y
- -
64.38
5Y
-99.37
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- DE United States of America
- IPO Date
- Jan 10, 2020
- CIK
- 0001785041
- Similar Companies
- Business
- CHP Merger Corp. (NASDAQ:CHPMW) operates as a blank check company whose sole purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses focused on the healthcare or healthcare-related industries in the United States; it currently conducts no significant operations of its own. Incorporated in 2019 and headquartered in Summit, New Jersey, the company targets opportunities within the healthcare sector, including medical technology and services, without offering specific products or services beyond its SPAC structure. In November 2021, CHP Merger Corp. announced a definitive business combination agreement with Accelus, a minimally invasive spine surgery company, valued at approximately $482 million, which was expected to rename the entity Accelus upon closing in early 2022; however, the parties mutually terminated the agreement in April 2022 due to adverse market conditions, leading to the company's liquidation and distribution of trust account funds to shareholders on April 25, 2022, with no subsequent mergers, acquisitions, or operational developments reported.